Chase C. Leavitt - May 25, 2021 Form 3 Insider Report for Oncternal Therapeutics, Inc. (ONCT)

Role
General Counsel/Secretary
Signature
/s/Chase C. Leavitt
Stock symbol
ONCT
Transactions as of
May 25, 2021
Transactions value $
$0
Form type
3
Date filed
5/27/2021, 06:06 PM
Next filing
Jun 15, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ONCT Stock Options May 25, 2021 Common Stock 235K $6.76 Direct F1
holding ONCT Stock Options May 25, 2021 Common Stock 65K $6.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One quarter of the shares subject to the stock options shall vest on April 12, 2022, and the remaining shares subject to the option shall vest in 36 equal monthly installments over the three-year period thereafter, subject to the Reporting Person's continued employment or service with the Issuer on each such date.

Remarks:

Exhibit 24 - Power of Attorney